Chronic gastritis
Information
- Disease name
- Chronic gastritis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04697186 | Completed | Phase 4 | Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy | January 7, 2021 | December 20, 2021 |
| NCT00996788 | Completed | Phase 3 | Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis | October 2007 | January 2012 |
| NCT01119768 | Completed | Phase 4 | Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients | April 2010 | June 2011 |
| NCT05073614 | Completed | N/A | Evaluation of Immunohistochemical Expression of Heparanase in Helicobacter Pylori-Associated Chronic Gastritis | July 1, 2021 | January 1, 2022 |
| NCT01817556 | Completed | Phase 4 | A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. | October 2012 | October 2013 |
| NCT02219529 | Completed | Phase 3 | Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases | August 2014 | February 2015 |
| NCT05014334 | Completed | Phase 4 | Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication | December 1, 2021 | June 30, 2022 |
| NCT02356679 | Completed | Phase 4 | Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients | August 2014 | June 2015 |
| NCT02658864 | Completed | Phase 1 | Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine Tablets | April 2005 | June 2005 |
| NCT03609892 | Completed | Phase 4 | Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy | August 1, 2018 | August 20, 2019 |
| NCT03847753 | Completed | Exploring the Comorbidity Between Mental Disorders and General Medical Conditions | January 1, 2000 | January 31, 2020 | |
| NCT04066530 | Completed | Phase 3 | A Study to Evaluate the Efficacy and Safety of AD-203 | September 23, 2019 | February 26, 2020 |
| NCT04189705 | Completed | Phase 3 | A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis | December 30, 2019 | April 23, 2020 |
| NCT04341454 | Completed | Phase 3 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis | June 2, 2020 | September 16, 2021 |
| NCT05021029 | Enrolling by invitation | A Study of Pre-Malignant Gastric Conditions | July 13, 2021 | October 31, 2025 | |
| NCT05666531 | Recruiting | Research on Innovative Diagnosis and Treatment System of Syndrome Differentiation of Zang-fu Viscera and Effectiveness Evaluation Based on Inter-Arm Blood Pressure Measured Simultaneously | January 1, 2022 | December 31, 2024 | |
| NCT05048069 | Recruiting | Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab. | October 7, 2021 | December 15, 2024 | |
| NCT00455806 | Unknown status | Phase 3 | Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection | January 2007 | February 2008 |
| NCT01813812 | Unknown status | Phase 3 | A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034 | October 2010 | |
| NCT02282670 | Unknown status | Phase 3 | A Study to Evaluate the Efficacy and Safety of DA-5204 | April 2014 | November 2014 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0005231
- MedGen concept unique identifier (MedGen Concept name)
- C0085695
- MedGen unique identifier (MedGen Concept name)
- 39089